An exploration of physical activity and sedentary behaviour during hospitalisation for acute exacerbation of chronic respiratory diseases

Boral, Ismet; Orme, Mark; Harvey-Dunstan, Theresa; Greening, Neil; Hussain, Syed Arshad; Morgan, Michael P.; Steiner, Michael; Singh, Sally

doi:10.1183/1393003.congress-2017.pa3458

Search citation statements

Order By: Relevance

Paper Sections

Select...

Group 11: Clinical Problems1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Dual long-acting β 2 -agonist plus long-acting muscarinic antagonist bronchodilator therapy was shown to significantly improve physical activity in the ACTIVATE study [ 5 ] as well as in a meta-analysis of eight randomised controlled trials (RCTs) [ 6 ]. Severe exacerbation symptoms were associated with reduced physical activity both in outpatients [ 7 ] and hospitalised patients, as seen in the REACH trial [ 8 ]. C hiaradia et al [ 9 ] addressed the impact of iron deficiency on daily physical activity, showing that it almost halved the number of steps per day (3628 versus 7072).…”

Section: Group 11: Clinical Problemsmentioning

confidence: 99%

European Respiratory Society International Congress 2017: highlights from the Clinical Assembly

Kahn

Mekov

Fregonese³

et al. 2018

ERJ Open Res

View full text Add to dashboard Cite

This article contains highlights and a selection of the scientific advances from the European Respiratory Society's Clinical Assembly (Assembly 1 and its six respective groups) that were presented at the 2017 European Respiratory Society International Congress in Milan, Italy. The most relevant topics from each of the groups will be discussed, covering a wide range of areas including clinical problems, rehabilitation and chronic care, thoracic imaging, interventional pulmonology, diffuse and parenchymal lung diseases, and general practice and primary care. In this comprehensive review, the newest research and actual data as well as award-winning abstracts and highlight sessions will be discussed.

show abstract